Biopharmaceutical

Summary

Table of Contents

  • Publication date: August 2011
Keywords : Biopharmaceutical

Cephalon, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Cephalon, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Cephalon is an international biopharmaceutical company engaged in discovering, developing and marketing drugs in three therapeutic areas: cen...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Robyn

(866) 682 9815

Send Your Request

Share

Biopharmaceutical Industry in the United States : Latest Reports

Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

Scil Biomedicals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Scil Biomedicals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

Navidea Biopharmaceuticals, Inc. (Formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Navidea Biopharmaceuticals, Inc. (Formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...


Biopharmaceutical Industry in the United States : Latest Downloads

MorphoSys AG - Company Report for Year 2012

MorphoSys AG - Company Report for Year 2012

  • Company report
  • November 2012
  • 19 pages

... Of going into even earlier- stage suffes. We also believe that gantenerumab has better properties than solanezumab, in that our antibody was deliberately made to bind and break down amyloid oligomers ...

Company Report: Bioprocessing for Year 2012

Company Report: Bioprocessing for Year 2012

  • Company report
  • October 2012
  • 4 pages

... Has yet to agree on definitions for both terms, which can have implications for risk mitigation and raw materials consistency in biopharmaceutical production. The panel will also address questions ...

Company Report: Biopharmaceutical for Year 2012

Company Report: Biopharmaceutical for Year 2012

  • Company report
  • October 2012
  • 32 pages

... Biomarin pharmaceutical inc. (Nasdaq: bmrn) is a multinational biopharmaceutical company that specializes in providing first-to-market therapeutics to patients with rare genetic diseases. Biomarin has ...


Related Market Segments :

Biopharmaceutical Company

Company Profiles

5 Companies

Cision AB

Sweden

Applied Materials Inc.

United States

OPKO Health Inc.

United States

Etec Systems Inc.

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.